GeneralBy Admin2026-04-201 min read

Sun Pharma Increases Overall Operational Efficiency by 40%

Sun Pharma Increases Overall Operational Efficiency by 40%

Sun Pharmaceutical Industries Limited, is the largest pharmaceutical company in India and the fourth largest specialty generic pharmaceutical company globally, operating in over 100 countries. Established in 1983, Sun Pharma specializes in a wide range of therapeutic areas, including psychiatry, cardiology, and oncology, and is known for its commitment to quality and innovation in pharmaceuticals.

Challenges

  • The dependence on manual calculations for critical processes has increased the risk of human error and time-consuming calculations that could delay production timelines.

  • Lack of user interlocks to prevent unauthorized use of equipment, with challenges in ensuring that only authorized personnel can access and operate specific equipment or areas.

  • Keeping track of the expiry dates of disinfectant solutions used in the production area, with the risk of using expired solutions compromising the sterilization process and product quality.

Ready to Transform Your Pharma Operations?

Discover how AmpleLogic's AI-powered platform can help you achieve operational excellence and regulatory compliance.

Our Global Offices

We are where you need us to be. Connecting globally, delivering locally.

India

Melange Tower, 2nd Floor, Wing-C, Patrika Nagar, HITEC City, Madhapur, Hyderabad - 500081, Telangana, India

United States (Dallas)

17330 Preston Road Suite 200D, Dallas, TX, 75252

Canada (North York, Toronto)

5255 Yonge Street Suite 201, North York, ON, M2N 6P4

Australia (Melbourne)

Level 14, 330 Collins Street, Melbourne, VIC, 3000

South Korea (Daegu)

Daegu Trade Centre, 8/F. 489, Dongdaegu-ro, Daegu, 41256

Ireland (Dublin)

Block 1, Blanchardstown Corporate Park Ballycoolen Road, Dublin, D15 AKK1

Singapore

1 Scotts Road, #24-10 Shaw Centre, Singapore, Singapore, 228208

Stay Ahead in Life Sciences

Get the latest product updates, compliance news, and industry insights delivered to your inbox.